• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌合并肝硬化患者手术切除的预测因素。

Factors predicting surgical resection in patients with intrahepatic cholangiocarcinoma and cirrhosis.

作者信息

Li Hao, Wu Jin-shu, Wang Xin-tian, Lv Pin, Gong Lian-sheng, Liu Gong, Tian Bu-ning, Li Ya-yong, Jiang Bo

机构信息

Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital , Changsha , China ;

出版信息

J Invest Surg. 2014 Aug;27(4):219-25. doi: 10.3109/08941939.2014.880138. Epub 2014 Jan 29.

DOI:10.3109/08941939.2014.880138
PMID:24476002
Abstract

Here, we investigate the potential factors that affect the outcome of patients with intrahepatic cholangiocarcinomas (ICC) and cirrhosis. We retrospectively reviewed the clinical data and pathological features of 58 patients with ICC and cirrhosis who underwent liver resection between July 2000 and March 2008, and analyzed the prognostic risk factors by means of univariate and multivariate analyses. The overall morbidity and mortality were 40% and 3.3%, respectively. The overall median survival was 24 months, and the 1-, 3-, and 5-year actuarial survival rates were 53%, 18%, and 10%, respectively. Univariate analysis showed that Child-Pugh classification, hypoalbuminemia, vascular invasion, lymphnodes metastasis, tumor-nodes-metastasis (TNM) staging system, positive surgical margins, and high perioperative blood transfusion volumes were all significantly associated with poor survival. Multivariate analysis confirmed that hypoalbuminemia, vascular invasion, positive surgical margins, and high perioperative blood transfusion volume were survival related, with hazard ratios (HR) of 2.58, 3.12, 3.57, and 1.98, respectively. Surgical resection is an effective treatment for patients affected by ICC and cirrhosis. Predictive factors, including hypoalbuminemia, vascular invasion, positive surgical margins, and high perioperative blood transfusion volumes are all related to poor survival.

摘要

在此,我们研究了影响肝内胆管癌(ICC)合并肝硬化患者预后的潜在因素。我们回顾性分析了2000年7月至2008年3月期间接受肝切除的58例ICC合并肝硬化患者的临床资料和病理特征,并通过单因素和多因素分析来分析预后危险因素。总体发病率和死亡率分别为40%和3.3%。总体中位生存期为24个月,1年、3年和5年的精算生存率分别为53%、18%和10%。单因素分析显示,Child-Pugh分级、低白蛋白血症、血管侵犯、淋巴结转移、肿瘤-淋巴结-转移(TNM)分期系统、手术切缘阳性和围手术期大量输血均与生存率低显著相关。多因素分析证实,低白蛋白血症、血管侵犯、手术切缘阳性和围手术期大量输血与生存相关,风险比(HR)分别为2.58、3.12、3.57和1.98。手术切除是治疗ICC合并肝硬化患者的有效方法。预测因素,包括低白蛋白血症、血管侵犯、手术切缘阳性和围手术期大量输血均与生存率低相关。

相似文献

1
Factors predicting surgical resection in patients with intrahepatic cholangiocarcinoma and cirrhosis.肝内胆管癌合并肝硬化患者手术切除的预测因素。
J Invest Surg. 2014 Aug;27(4):219-25. doi: 10.3109/08941939.2014.880138. Epub 2014 Jan 29.
2
Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.肝内胆管癌:手术切除后的预后因素
World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.
3
Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.肝硬化对肝内胆管癌手术治疗预后的价值。
J Gastrointest Surg. 2011 Apr;15(4):608-13. doi: 10.1007/s11605-011-1419-8. Epub 2011 Jan 19.
4
Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.乙型肝炎病毒相关性肝内胆管癌切除术后的预后
World J Gastroenterol. 2015 Jan 21;21(3):935-43. doi: 10.3748/wjg.v21.i3.935.
5
Survival analysis of intrahepatic cholangiocarcinoma after resection.肝内胆管癌切除术后的生存分析。
Ann Surg Oncol. 2010 Jul;17(7):1823-30. doi: 10.1245/s10434-010-0938-y. Epub 2010 Feb 18.
6
Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.肝内胆管细胞癌根治性切除术后的预后与内脏浸润密切相关——单中心连续 102 例肝切除术的回顾性队列研究。
Int J Surg. 2018 Jul;55:193-200. doi: 10.1016/j.ijsu.2018.05.027. Epub 2018 May 25.
7
Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.切除与经肝动脉化疗栓塞治疗进展期肝内胆管细胞癌的疗效比较——单中心经验
Eur J Surg Oncol. 2013 Jun;39(6):593-600. doi: 10.1016/j.ejso.2013.03.010. Epub 2013 Apr 20.
8
Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma.肝内胆管癌的手术结果及预后因素
World J Surg. 2008 Dec;32(12):2675-80. doi: 10.1007/s00268-008-9778-3.
9
Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.肝内胆管癌根治性切除术后的分期、预后因素及辅助治疗
Liver Int. 2014 Jul;34(6):953-60. doi: 10.1111/liv.12364. Epub 2013 Nov 20.
10
Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.肿块型肝内胆管癌的外科治疗:一项针对107例患者的11年西方单中心经验。
Ann Surg Oncol. 2009 Feb;16(2):404-12. doi: 10.1245/s10434-008-0227-1. Epub 2008 Nov 27.

引用本文的文献

1
Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma.肝门部胆管癌手术治疗的临床特征及长期生存预测。
PLoS One. 2024 Jul 1;19(7):e0304838. doi: 10.1371/journal.pone.0304838. eCollection 2024.
2
Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.肝硬化对肝内胆管细胞癌患者肝切除术后预后的影响。
Can J Gastroenterol Hepatol. 2017;2017:6543423. doi: 10.1155/2017/6543423. Epub 2017 Nov 12.
3
Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.
预测肝切除术后肝内胆管癌复发的风险分层系统。
BMC Cancer. 2017 Jul 3;17(1):464. doi: 10.1186/s12885-017-3464-5.
4
Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma.格拉斯哥预后评分可预测肝内胆管癌的预后。
Mol Clin Oncol. 2017 Apr;6(4):566-574. doi: 10.3892/mco.2017.1166. Epub 2017 Feb 16.
5
Perioperative blood transfusion is not associated with overall survival or time to recurrence after resection of perihilar cholangiocarcinoma.围手术期输血与肝门部胆管癌切除术后的总生存期或复发时间无关。
HPB (Oxford). 2016 Mar;18(3):262-70. doi: 10.1016/j.hpb.2015.08.004. Epub 2016 Jan 6.